AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life...more
Access to capital is critical for life sciences companies. Securing funding can be a lengthy and complex process compounded by the need to plan for various exit transaction scenarios.
Register now for this one-hour,...more
9/27/2019
/ Business Development ,
Business Ownership ,
Capital Raising ,
Continuing Legal Education ,
Debt Financing ,
Emerging Growth Companies ,
Exit Strategies ,
Initial Public Offering (IPO) ,
Investment Management ,
Investors ,
Life Sciences ,
Private Equity ,
Publicly-Traded Companies ,
Regulatory Requirements ,
Securities Transactions ,
Seed Financing ,
Startups ,
Venture Capital ,
Webinars